Elisabeth Mack

1.4k total citations
33 papers, 465 citations indexed

About

Elisabeth Mack is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Elisabeth Mack has authored 33 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Elisabeth Mack's work include Cancer Genomics and Diagnostics (9 papers), COVID-19 Clinical Research Studies (5 papers) and Acute Myeloid Leukemia Research (5 papers). Elisabeth Mack is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), COVID-19 Clinical Research Studies (5 papers) and Acute Myeloid Leukemia Research (5 papers). Elisabeth Mack collaborates with scholars based in Germany, Austria and United Kingdom. Elisabeth Mack's co-authors include Winfried V. Kern, A. Engel, P. Kern, Thorsten Stiewe, Andreas Neubauer, Cornelia Brendel, Marijke van Rikxoort, Franz Rödel, Yvonne Voges and Susanne Barth and has published in prestigious journals such as Blood, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Elisabeth Mack

29 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Mack Germany 10 231 212 93 75 54 33 465
G Pizzorno United States 13 301 1.3× 199 0.9× 55 0.6× 67 0.9× 45 0.8× 19 558
Jessica L. Slack United States 12 273 1.2× 148 0.7× 70 0.8× 73 1.0× 19 0.4× 13 619
Sherly Mosessian United States 8 423 1.8× 144 0.7× 59 0.6× 67 0.9× 84 1.6× 12 627
Fonda M. Newcomb United States 8 289 1.3× 202 1.0× 30 0.3× 82 1.1× 86 1.6× 12 601
Costakis Frangou United States 7 165 0.7× 74 0.3× 45 0.5× 31 0.4× 56 1.0× 7 443
Miguel Marino United States 4 155 0.7× 192 0.9× 102 1.1× 30 0.4× 9 0.2× 4 467
Oliver Feyen Germany 16 250 1.1× 176 0.8× 80 0.9× 117 1.6× 118 2.2× 32 841
Maria Chiara Scaini Italy 11 286 1.2× 252 1.2× 131 1.4× 38 0.5× 10 0.2× 21 477
Marina Lanciotti Italy 17 267 1.2× 129 0.6× 60 0.6× 38 0.5× 160 3.0× 51 733
Paola Zancai Italy 13 242 1.0× 269 1.3× 31 0.3× 65 0.9× 39 0.7× 18 516

Countries citing papers authored by Elisabeth Mack

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Mack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Mack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Mack more than expected).

Fields of papers citing papers by Elisabeth Mack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Mack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Mack. The network helps show where Elisabeth Mack may publish in the future.

Co-authorship network of co-authors of Elisabeth Mack

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Mack. A scholar is included among the top collaborators of Elisabeth Mack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Mack. Elisabeth Mack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mack, Hildegard I. D., Andrea Nist, Thorsten Stiewe, et al.. (2025). Detection of minimal residual disease in circulating cell-free DNA in acute myeloid leukemia. Scientific Reports. 15(1). 32679–32679.
2.
Gremke, Niklas, Julia Teply‐Szymanski, A. Stroh, et al.. (2024). NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors—A Retrospective Molecular Tumor Board Analysis. Cancers. 16(8). 1561–1561. 3 indexed citations
3.
Potaczek, Daniel P., David Falck, Wilhelm Bertrams, et al.. (2024). Glycosylation signature of plasma IgA of critically ill COVID-19 patients. Frontiers in Immunology. 15. 1439248–1439248. 1 indexed citations
4.
5.
Teply‐Szymanski, Julia, Ramona Erber, Annette Lebeau, et al.. (2023). Klinisch relevante molekularpathologische Diagnostik beim Mammakarzinom. PubMed. 44(1). 39–49. 2 indexed citations
6.
Bauer, Christian, Elisabeth Mack, Alexandra Fischer, et al.. (2023). Impaired systemic nucleocapsid antigen clearance in severe COVID‐19. Journal of Medical Virology. 95(8). e29032–e29032. 2 indexed citations
7.
Thrun, Michael C., Elisabeth Mack, Andreas Neubauer, et al.. (2022). A Bioinformatics View on Acute Myeloid Leukemia Surface Molecules by Combined Bayesian and ABC Analysis. Bioengineering. 9(11). 642–642. 4 indexed citations
8.
9.
Mack, Elisabeth, Ellen Wollmer, Christoph Mann, et al.. (2022). Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells. Annals of Hematology. 101(4). 811–824. 16 indexed citations
10.
Mack, Hildegard I. D., et al.. (2022). Further Extension of Lifespan by Unc-43/CaMKII and Egl-8/PLCβ Mutations in Germline-Deficient Caenorhabditis elegans. Cells. 11(22). 3527–3527. 3 indexed citations
11.
Mack, Hildegard I. D., et al.. (2022). Regulation of fatty acid desaturase- and immunity gene-expression by mbk-1/DYRK1A in Caenorhabditis elegans. BMC Genomics. 23(1). 25–25. 8 indexed citations
12.
Nist, Andrea, Marco Mernberger, Thorsten Stiewe, et al.. (2021). Superior Overall Survival in Patients with Colorectal Cancer, Regular Aspirin Use, and Combined Wild-Type PIK3CA and KRAS-Mutated Tumors. Cancers. 13(19). 4959–4959. 5 indexed citations
13.
Neubauer, Andreas, Johannes Johow, Elisabeth Mack, et al.. (2021). The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS). Leukemia. 35(10). 2917–2923. 16 indexed citations
14.
Neubauer, Andreas, Johannes Johow, Elisabeth Mack, et al.. (2021). Publisher Correction: The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS). Leukemia. 35(10). 3038–3038. 2 indexed citations
15.
Metzger, Patrick, Martin Boeker, Till Acker, et al.. (2020). Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal. Diagnostics. 10(2). 93–93. 25 indexed citations
16.
Brendel, Cornelia, et al.. (2020). Expression of β-1,4-galactosyltransferases during Aging in <b><i>Caenorhabditis elegans</i></b>. Gerontology. 66(6). 571–581. 5 indexed citations
17.
Greene, Brandon, Christina Barckhausen, Raimo Hartmann, et al.. (2017). Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia. Leukemia Research. 62. 56–63. 24 indexed citations
18.
Bretz, Anne Catherine, et al.. (2011). Targeting p73 in cancer. Cancer Letters. 332(2). 229–236. 33 indexed citations
19.
Mack, Elisabeth, Andreas Neubauer, & Cornelia Brendel. (2007). Comparison of RNA yield from small cell populations sorted by flow cytometry applying different isolation procedures. Cytometry Part A. 71A(6). 404–409. 17 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Pizzorno Breakdown of academic impact, for papers by Jessica L. Slack Breakdown of academic impact, for papers by Sherly Mosessian Breakdown of academic impact, for papers by Fonda M. Newcomb Breakdown of academic impact, for papers by Costakis Frangou Breakdown of academic impact, for papers by Miguel Marino Breakdown of academic impact, for papers by Oliver Feyen Breakdown of academic impact, for papers by Maria Chiara Scaini Breakdown of academic impact, for papers by Marina Lanciotti Breakdown of academic impact, for papers by Paola Zancai
Rankless by CCL
2026